HEADER HYDROLASE 03-NOV-09 3KJQ TITLE CASPASE 8 WITH COVALENT INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CASPASE-8; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: CASP-8, ICE-LIKE APOPTOTIC PROTEASE 5, MORT1-ASSOCIATED CED- COMPND 5 3 HOMOLOG, MACH, FADD-HOMOLOGOUS ICE/CED-3-LIKE PROTEASE, FADD-LIKE COMPND 6 ICE, FLICE, APOPTOTIC CYSTEINE PROTEASE, APOPTOTIC PROTEASE MCH-5, COMPND 7 CAP4, CASPASE-8 SUBUNIT P18, CASPASE-8 SUBUNIT P10; COMPND 8 EC: 3.4.22.61; COMPND 9 ENGINEERED: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: CASPASE-8; COMPND 12 CHAIN: B; COMPND 13 SYNONYM: CASP-8, ICE-LIKE APOPTOTIC PROTEASE 5, MORT1-ASSOCIATED CED- COMPND 14 3 HOMOLOG, MACH, FADD-HOMOLOGOUS ICE/CED-3-LIKE PROTEASE, FADD-LIKE COMPND 15 ICE, FLICE, APOPTOTIC CYSTEINE PROTEASE, APOPTOTIC PROTEASE MCH-5, COMPND 16 CAP4, CASPASE-8 SUBUNIT P18, CASPASE-8 SUBUNIT P10; COMPND 17 EC: 3.4.22.61; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CASP8, MCH5; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: CASP8, MCH5; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS CASPASE 8, APOPTOSIS, KINETICS, PEPTIDOMIMETIC INHIBITOR, URAZOLE, KEYWDS 2 DISEASE MUTATION, PHOSPHOPROTEIN, PROTEASE, THIOL PROTEASE, ZYMOGEN, KEYWDS 3 ALLOSTERIC, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR S.KAMTEKAR,W.WATT,B.C.FINZEL,M.S.HARRIS,J.BLINN,Z.WANG,A.G.TOMASSELLI REVDAT 1 11-AUG-10 3KJQ 0 JRNL AUTH Z.WANG,W.WATT,N.A.BROOKS,M.S.HARRIS,J.URBAN,D.BOATMAN, JRNL AUTH 2 M.MCMILLAN,M.KAHN,R.L.HEINRIKSON,B.C.FINZEL,A.J.WITTWER, JRNL AUTH 3 J.BLINN,S.KAMTEKAR,A.G.TOMASSELLI JRNL TITL KINETIC AND STRUCTURAL CHARACTERIZATION OF CASPASE-3 AND JRNL TITL 2 CASPASE-8 INHIBITION BY A NOVEL CLASS OF IRREVERSIBLE JRNL TITL 3 INHIBITORS. JRNL REF BIOCHIM.BIOPHYS.ACTA V.1804 1817 2010 JRNL REFN ISSN 0006-3002 JRNL PMID 20580860 JRNL DOI 10.1016/J.BBAPAP.2010.05.007 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 26415 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.185 REMARK 3 R VALUE (WORKING SET) : 0.182 REMARK 3 FREE R VALUE : 0.207 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2933 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.85 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1880 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.92 REMARK 3 BIN R VALUE (WORKING SET) : 0.2410 REMARK 3 BIN FREE R VALUE SET COUNT : 198 REMARK 3 BIN FREE R VALUE : 0.2930 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1924 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 146 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 12.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.64000 REMARK 3 B22 (A**2) : 0.64000 REMARK 3 B33 (A**2) : -0.96000 REMARK 3 B12 (A**2) : 0.32000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.117 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.110 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.063 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.957 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.950 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.936 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2036 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1366 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2757 ; 1.242 ; 1.989 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3348 ; 0.877 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 248 ; 5.966 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 94 ;35.464 ;24.787 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 355 ;12.755 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;15.512 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 299 ; 0.075 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2269 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 384 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 376 ; 0.190 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 1411 ; 0.181 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 981 ; 0.180 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 989 ; 0.082 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 124 ; 0.116 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 15 ; 0.162 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 52 ; 0.224 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 10 ; 0.126 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1250 ; 0.751 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 489 ; 0.137 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1981 ; 1.205 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 876 ; 1.924 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 772 ; 2.968 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3KJQ COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 05-NOV-09. REMARK 100 THE RCSB ID CODE IS RCSB056077. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 17-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : SI(111) DOUBLE-CRYSTAL REMARK 200 MONOCHROMATOR REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29346 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.99 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2 MICROLITERS OF 100 MM INHIBITOR REMARK 280 STOCK IN DMSO WAS ADDED TO 100 MICROLITERS OF 8.4 MG/ML PROTEIN REMARK 280 IN 20 MM TRIS, 100 MM DTT, PH 8.0. PROTEIN SOLUTION WAS MIXED REMARK 280 WITH AN EQUAL VOLUME OF WELL SOLUTION (1.0-1.1 M CITRATE, 50 MM REMARK 280 HEPES OR PIPES PH 6.5, 25 MM DTT), VAPOR DIFFUSION, TEMPERATURE REMARK 280 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+2/3 REMARK 290 6555 -X,-X+Y,-Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 43.61567 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 87.23133 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 87.23133 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 43.61567 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 13780 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -90.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 -0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 43.61567 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 211 REMARK 465 PRO A 212 REMARK 465 ARG A 213 REMARK 465 GLU A 214 REMARK 465 GLN A 215 REMARK 465 ASP A 216 REMARK 465 SER A 217 REMARK 465 GLU A 218 REMARK 465 SER A 219 REMARK 465 GLN A 220 REMARK 465 THR A 221 REMARK 465 LEU A 222 REMARK 465 LEU B 385 REMARK 465 SER B 386 REMARK 465 SER B 387 REMARK 465 PRO B 388 REMARK 465 GLN B 389 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 246 CD CE NZ REMARK 470 GLU A 372 CG CD OE1 OE2 REMARK 470 ASP B 479 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A 228 70.80 -151.26 REMARK 500 ASN B 408 -4.38 79.35 REMARK 500 GLU B 417 -30.21 -139.60 REMARK 500 REMARK 500 REMARK: NULL REMARK 610 REMARK 610 MISSING HETEROATOM REMARK 610 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 610 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 610 I=INSERTION CODE): REMARK 610 M RES C SSEQI REMARK 610 B94 A 480 REMARK 610 B94 A 481 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B94 A 480 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B94 A 481 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3KJF RELATED DB: PDB REMARK 900 CASPASE 3 BOUND TO A COVALENT INHIBITOR REMARK 900 RELATED ID: 3KJN RELATED DB: PDB REMARK 900 CASPASE 8 BOUND TO A COVALENT INHIBITOR DBREF 3KJQ A 211 374 UNP Q14790 CASP8_HUMAN 211 374 DBREF 3KJQ B 385 479 UNP Q14790 CASP8_HUMAN 385 479 SEQRES 1 A 164 SER PRO ARG GLU GLN ASP SER GLU SER GLN THR LEU ASP SEQRES 2 A 164 LYS VAL TYR GLN MET LYS SER LYS PRO ARG GLY TYR CYS SEQRES 3 A 164 LEU ILE ILE ASN ASN HIS ASN PHE ALA LYS ALA ARG GLU SEQRES 4 A 164 LYS VAL PRO LYS LEU HIS SER ILE ARG ASP ARG ASN GLY SEQRES 5 A 164 THR HIS LEU ASP ALA GLY ALA LEU THR THR THR PHE GLU SEQRES 6 A 164 GLU LEU HIS PHE GLU ILE LYS PRO HIS ASP ASP CYS THR SEQRES 7 A 164 VAL GLU GLN ILE TYR GLU ILE LEU LYS ILE TYR GLN LEU SEQRES 8 A 164 MET ASP HIS SER ASN MET ASP CYS PHE ILE CYS CYS ILE SEQRES 9 A 164 LEU SER HIS GLY ASP LYS GLY ILE ILE TYR GLY THR ASP SEQRES 10 A 164 GLY GLN GLU ALA PRO ILE TYR GLU LEU THR SER GLN PHE SEQRES 11 A 164 THR GLY LEU LYS CYS PRO SER LEU ALA GLY LYS PRO LYS SEQRES 12 A 164 VAL PHE PHE ILE GLN ALA CYS GLN GLY ASP ASN TYR GLN SEQRES 13 A 164 LYS GLY ILE PRO VAL GLU THR ASP SEQRES 1 B 95 LEU SER SER PRO GLN THR ARG TYR ILE PRO ASP GLU ALA SEQRES 2 B 95 ASP PHE LEU LEU GLY MET ALA THR VAL ASN ASN CYS VAL SEQRES 3 B 95 SER TYR ARG ASN PRO ALA GLU GLY THR TRP TYR ILE GLN SEQRES 4 B 95 SER LEU CYS GLN SER LEU ARG GLU ARG CYS PRO ARG GLY SEQRES 5 B 95 ASP ASP ILE LEU THR ILE LEU THR GLU VAL ASN TYR GLU SEQRES 6 B 95 VAL SER ASN LYS ASP ASP LYS LYS ASN MET GLY LYS GLN SEQRES 7 B 95 MET PRO GLN PRO THR PHE THR LEU ARG LYS LYS LEU VAL SEQRES 8 B 95 PHE PRO SER ASP HET B94 A 480 29 HET B94 A 481 19 HETNAM B94 (3S)-3-({[(5S,8R)-2-(3-CARBOXYPROPYL)-8-(2-{[(4- HETNAM 2 B94 CHLOROPHENYL)ACETYL]AMINO}ETHYL)-1,3-DIOXO-2,3,5,8- HETNAM 3 B94 TETRAHYDRO-1H-[1,2,4]TRIAZOLO[1,2-A]PYRIDAZIN-5- HETNAM 4 B94 YL]CARBONYL}AMINO)-4-OXOPENTANOIC ACID FORMUL 3 B94 2(C26 H30 CL N5 O9) FORMUL 5 HOH *146(H2 O) HELIX 1 1 PHE A 244 VAL A 251 1 8 HELIX 2 2 PRO A 252 HIS A 255 5 4 HELIX 3 3 GLY A 262 LEU A 277 1 16 HELIX 4 4 THR A 288 MET A 302 1 15 HELIX 5 5 ILE A 333 SER A 338 1 6 HELIX 6 6 GLN A 339 THR A 341 5 3 HELIX 7 7 CYS A 345 ALA A 349 5 5 HELIX 8 8 TRP B 420 CYS B 433 1 14 HELIX 9 9 PRO B 434 GLY B 436 5 3 HELIX 10 10 ASP B 438 ASN B 452 1 15 SHEET 1 A 6 GLU A 280 ASP A 285 0 SHEET 2 A 6 TYR A 235 ASN A 240 1 N ASN A 240 O HIS A 284 SHEET 3 A 6 PHE A 310 LEU A 315 1 O CYS A 313 N ILE A 239 SHEET 4 A 6 LYS A 353 GLN A 358 1 O GLN A 358 N ILE A 314 SHEET 5 A 6 PHE B 399 MET B 403 1 O GLY B 402 N PHE A 355 SHEET 6 A 6 GLN B 465 PHE B 468 -1 O THR B 467 N LEU B 401 SHEET 1 B 3 GLY A 318 ASP A 319 0 SHEET 2 B 3 ILE A 322 TYR A 324 -1 O ILE A 322 N ASP A 319 SHEET 3 B 3 GLU A 330 PRO A 332 -1 O ALA A 331 N ILE A 323 SHEET 1 C 2 ARG B 413 ASN B 414 0 SHEET 2 C 2 GLY B 418 THR B 419 -1 O GLY B 418 N ASN B 414 LINK SG CYS A 360 C1 B94 A 480 1555 1555 1.81 CISPEP 1 LYS A 231 PRO A 232 0 -0.13 SITE 1 AC1 12 ARG A 258 ARG A 260 HIS A 317 GLY A 318 SITE 2 AC1 12 GLN A 358 CYS A 360 HOH A 519 HOH A 542 SITE 3 AC1 12 HOH A 545 SER B 411 TYR B 412 ARG B 413 SITE 1 AC2 8 TYR A 334 THR A 337 SER A 338 GLU B 396 SITE 2 AC2 8 PHE B 399 GLN B 465 THR B 467 THR B 469 CRYST1 63.974 63.974 130.847 90.00 90.00 120.00 P 31 2 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015631 0.009025 0.000000 0.00000 SCALE2 0.000000 0.018050 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007643 0.00000